Galectin Therapeutics Inc. · NASDAQ:GALT

Richard E. Uihlein exercised options for 34,376,167 Galectin Therapeutics Inc. shares (Form 4)

Traded Jul 31, 2026 · Filed Aug 4, 2026

On Jul 31, 2026, Richard E. Uihlein (Director, 10% owner) exercised options for 34,376,167 Galectin Therapeutics Inc. shares at an average US$3.08 for US$106M, leaving 44,713,843 shares. Filed Aug 4, 2026 (Form 4).

Options exercised
34,376,167 shares
Price
US$3.08 average (US$3.00 to US$4.05)
Value
US$106M
Holding after
44,713,843 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 31, 2026Common StockOption exercise31,825,235US$3.0042,162,911Indirect
Jul 31, 2026Common StockOption exercise2,550,932US$4.0544,713,843Indirect

Source

View original at SEC

Related